Intellectual Property India Publishes Patent Application for 'Compositions Comprising A Bispecific Gprc5d/Cd3 Antibody' Filed by Janssen Biotech, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517090844 A) filed by Janssen Biotech, Inc., Horsham, U.S.A., on Sept. 23, for 'compositions comprising a bispecific gprc5d/cd3 antibody.'

Inventor(s) include Vargo, Kevin B.; Heinaman, Daniel P; Javiya, Curie K.; and Muzammil, Salman.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are aqueous pharmaceutical compositions comprising formulations of a bispecific GPRC5D/CD3 antibody or an antigen-binding fragment thereof and methods of preparing the same. Also provided herein are methods of treating cancer in a subject in need thereof by administering to the subject the aqueous pharmaceutical compositions as disclosed herein. Further provided herein are kits and articles of manufacture comprising the aqueous pharmaceutical compositions as disclosed herein."

The patent application was internationally filed on Feb. 27, 2024, under International application No.PCT/IB2024/051855.

Disclaimer: Curated by HT Syndication.